Ritsa Pharma Private Limited, a active private limited company, was established on 21 October 2020 in Tirumalagiri, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290TG2020PTC145093. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹31.58 Cr.
Employing 33 professional, Its leadership includes Chandrasekhar Penugonda (Director), Ganji Kishore Kumar (Director), Narendra Babu Vutla (Director). Past directors included Nirmala Bhattaram, Chandrasekhar Penugonda, Narendra Babu Vutla. It holds ₹4.52 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3600, Plot No. 4 Survey Nos. 101,101/2 & 340, Lalgadi Malakpet (Village), Genome Valley, Tirumalagiri, Telangana, 500101.
U24290TG2020PTC145093
145093
21 October 2020
₹40.00 Cr
₹31.58 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Ritsa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrasekhar Penugonda | Director | 10 Apr 2024 | Current |
| Ganji Kishore Kumar | Director | 21 Oct 2020 | Current |
| Narendra Babu Vutla | Director | 07 Jul 2023 | Current |
| Srilalitha Bhattaram | Director | 24 Feb 2021 | Current |
| Manaswini Vemulapalli | Nominee Director | 09 Aug 2021 | Current |
| Venkateswara Rao Yarlagadda | Director | 21 Oct 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Feb 2021 | Past |
| Pramod Abcsdd | Additional Director | 09 May 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 21 Oct 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ritsa Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 93.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 4182.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ritsa Pharma had a public holding of 50.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹45,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2023 | State Bank Of India | ₹4.52 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ritsa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ritsa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ritsa Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Venkata Subramanya Ravi Kumar Gannavarapu was appointed as a Company Secretary was appointed as a Company Secretary on 11 Sep 2025 & has been associated with this company since 3 months 21 days . was documented.
Progress on Ritsa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Chandrasekhar Penugonda was appointed as a Director was appointed as a Director on 10 Apr 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
The activity Ritsa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with State Bank Of India amounted to Rs. 4.52 Cr with Charge ID 100827380 was registered on 21 Nov 2023. was recorded as a recent event.
Progress on Narendra Babu Vutla was appointed as a Director was appointed as a Director on 07 Jul 2023 & has been associated with this company since 2 years 5 months . was documented.
The CIN of Ritsa Pharma Private Limited is U24290TG2020PTC145093.
Ritsa Pharma Private Limited is headquartered at 3600, Plot No. 4 Survey Nos. 101,101/2 & 340, Lalgadi Malakpet (Village), Genome Valley, Tirumalagiri, Telangana, 500101.
Ritsa Pharma Private Limited was incorporated on 21 October 2020.
The current directors of Ritsa Pharma Private Limited are
The primary industry of Ritsa Pharma Private Limited is Manufacturing.
Ritsa Pharma Private Limited is unlisted.
The authorized capital of Ritsa Pharma Private Limited is ₹40.00 Cr, and the paid-up capital is ₹31.58 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX